These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36868037)

  • 1. Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy.
    Abate F; Russo M; Ricciardi C; Tepedino MF; Romano M; Erro R; Pellecchia MT; Amboni M; Barone P; Picillo M
    Parkinsonism Relat Disord; 2023 Apr; 109():105345. PubMed ID: 36868037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote at-home wearable-based gait assessments in Progressive Supranuclear Palsy compared to Parkinson's Disease.
    Sharma M; Mishra RK; Hall AJ; Casado J; Cole R; Nunes AS; Barchard G; Vaziri A; Pantelyat A; Wills AM
    BMC Neurol; 2023 Dec; 23(1):434. PubMed ID: 38082255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.
    Hewer S; Varley S; Boxer AL; Paul E; Williams DR;
    Mov Disord; 2016 Oct; 31(10):1574-1577. PubMed ID: 27324431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.
    Bang J; Lobach IV; Lang AE; Grossman M; Knopman DS; Miller BL; Schneider LS; Doody RS; Lees A; Gold M; Morimoto BH; Boxer AL;
    Parkinsonism Relat Disord; 2016 Jul; 28():41-48. PubMed ID: 27172829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical rating scale for progressive supranuclear palsy.
    Golbe LI; Ohman-Strickland PA
    Brain; 2007 Jun; 130(Pt 6):1552-65. PubMed ID: 17405767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy-Richardson Syndrome.
    Xie T; Wills AM; Liao C; Dale ML; Ramsden DB; Padmanaban M; Abou Chaar W; Pantelyat A; Golbe LI
    Mov Disord; 2023 Feb; 38(2):304-312. PubMed ID: 36573662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments.
    Wills AM; Pantelyat A; Espay A; Chan J; Litvan I; Xie T; Dale ML; Gunzler SA; Tartaglia MC; Fox SH; Rodriguez-Porcel F; Sharma M; Lang AE; Boxer AL; ; Golbe LI
    Mov Disord; 2022 Jun; 37(6):1265-1271. PubMed ID: 35363932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy.
    Weng R; Wei X; Yu B; Zhu S; Yang X; Xie F; Zhang M; Jiang Y; Feng ZP; Sun HS; Xia Y; Jin K; Chan P; Wang Q; Gao X
    Parkinsonism Relat Disord; 2018 Jul; 52():37-42. PubMed ID: 29574085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Convenient Prognostic Tool and Staging System for Progressive Supranuclear Palsy.
    Golbe LI; Ohman-Strickland P; Beisser EB; Elghoul FT
    Mov Disord Clin Pract; 2020 Aug; 7(6):664-671. PubMed ID: 32775512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
    Rezvanian S; Litvan I; Standaert D; Jankovic J; Reich SG; Hall D; Shprecher DR; Bordelon Y; Dubinsky R; Kluger B
    Parkinsonism Relat Disord; 2020 Sep; 78():56-60. PubMed ID: 32731191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning.
    De Vos M; Prince J; Buchanan T; FitzGerald JJ; Antoniades CA
    Gait Posture; 2020 Mar; 77():257-263. PubMed ID: 32078894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.
    Clerici I; Ferrazzoli D; Maestri R; Bossio F; Zivi I; Canesi M; Pezzoli G; Frazzitta G
    PLoS One; 2017; 12(2):e0170927. PubMed ID: 28158197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale.
    Pantelyat A; Higginbotham L; Rosenthal L; Lanham D; Nesspor V; AlSalihi M; Bang J; Wang J; Albert M
    Neurodegener Dis; 2020; 20(4):139-146. PubMed ID: 33789283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy.
    Ricciardi C; Pisani N; Donisi L; Abate F; Amboni M; Barone P; Picillo M; Cesarelli M; Amato F
    Sensors (Basel); 2023 Dec; 23(24):. PubMed ID: 38139705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation predicts disease progression in progressive supranuclear palsy.
    Malpetti M; Passamonti L; Jones PS; Street D; Rittman T; Fryer TD; Hong YT; Vàsquez Rodriguez P; Bevan-Jones WR; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):769-775. PubMed ID: 33731439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
    Choi JH; Kim H; Shin JH; Lee JY; Kim HJ; Kim JM; Jeon B
    J Neurol; 2021 Mar; 268(3):967-977. PubMed ID: 32959131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
    Tsai RM; Lobach I; Bang J; Whitwell JL; Senjem ML; Jack CR; Rosen H; Miller B; Boxer AL;
    Parkinsonism Relat Disord; 2016 Jul; 28():29-35. PubMed ID: 27132501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balance and gait in progressive supranuclear palsy: a narrative review of objective metrics and exercise interventions.
    Dale ML; Silva-Batista C; de Almeida FO; Horak FB
    Front Neurol; 2023; 14():1212185. PubMed ID: 37426438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral pedunculopontine nucleus stimulation for progressive supranuclear palsy.
    Doshi PK; Desai JD; Karkera B; Wadia PM
    Stereotact Funct Neurosurg; 2015; 93(1):59-65. PubMed ID: 25662728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.